Heparin disaccharide I-A sodium salt (CAS 136098-00-5)

Heparin disaccharide I-A sodium salt, a fundamental component in glycobiology research, has garnered significant attention for its pivotal role in elucidating carbohydrate-protein interactions and their implications in various biological processes. This chemical entity, derived from heparin, a sulfated glycosaminoglycan, possesses distinct structural features that facilitate its binding to a myriad of biomolecules, including growth factors, cytokines, and cell surface receptors. Research endeavors have centered on unraveling the precise mechanisms through which heparin disaccharide I-A modulates cellular signaling cascades implicated in inflammation, angiogenesis, and tissue regeneration. Moreover, its involvement in regulating the activity of enzymes such as heparanase, which orchestrates extracellular matrix remodeling and cancer metastasis, has been extensively investigated. Furthermore, heparin disaccharide I-A has found application in biomaterial engineering, where its incorporation into scaffolds and hydrogels has been explored for tissue engineering and regenerative medicine purposes. By harnessing the unique properties of heparin disaccharide I-A, researchers aim to deepen their understanding of fundamental biological mechanisms and develop innovative strategies for interventions. Ongoing research initiatives continue to delve into the multifaceted roles of heparin disaccharide I-A across diverse biological contexts, driving advancements in basic science and translational research.